Nebivolol compared with metoprolol for erectile function in males undergoing coronary artery bypass graft

Creative Commons License

Aldemir M., Keles I., Karalar M., Tecer E., Adali F., Pektas M. B. , ...More

ANATOLIAN JOURNAL OF CARDIOLOGY, vol.16, no.2, pp.131-136, 2016 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 16 Issue: 2
  • Publication Date: 2016
  • Doi Number: 10.5152/akd.2015.5936
  • Journal Name: ANATOLIAN JOURNAL OF CARDIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.131-136
  • Kütahya Health Sciences University Affiliated: Yes

Abstract

Objective: The aim of this study was to evaluate erectile function in males undergoing coronary artery bypass graft (CABG) while on two different adrenoceptor beta-blocker regimens, namely nebivolol and metoprolol. We hypothesize that the negative effects of cardiopulmonary bypass on erectile function may be possibly attenuated by preferring a vasodilating selective beta(1)-blocker, nebivolol, to metoprolol as an anti-ischemic and antiarrhythmic agent in males undergoing CABG.